摘要
目的:探讨我国制售假药的现状、特点及其监管对策。方法:以我国公安机关2011-2015年侦办的7 500余起假药案件为基础,选择其中50起涉案假药数量大、金额高、人数多、地域广和社会影响较大的典型案件的相关数据进行分析,并提出监管对策。结果与结论:我国假药案件和涉案人数整体上呈快速增长态势,分别从2011年的近500起、900人增长到2015年的近2 500起、6 000人。50起典型案件中,涉案假药种类多集中于治疗性功能障碍药(占23.8%)、美容药和减肥药(占19.6%)、止咳平喘药(占14.2%)、治疗风湿骨病药(占13.9%)、抗糖尿病药(占7.3%)、抗肿瘤药(占6.6%)等;网络销售假药有42起(占84%);无证生产销售假药有46起(占92%);非法代购假药有3起(占6%)。整体来看,我国制售假药具有涉案金额高、违法犯罪活动隐蔽、受害者多为低收入人群等特点。建议加强假药监管工作,创新监管方式;加强药品监管部门与公安机关联合执法,顺畅行政执法与刑事司法;创新情报信息运行体制机制,建立信息共享平台与信息通报机制;强化互联网监测,加强与制药企业合作;加强舆论宣传,震慑犯罪分子等。
OBJECTIVE： To investigate the status quo and characteristics of manufacturing and selling counterfeit drugs in China, and to explore supervision strategies. METHODS： Among 7 500 counterfeit drugs cases investigated by public security organization during 2011-2015, 50 typical cases, which involved large amount of counterfeit drugs, large sum of money, a large number of people, a broad geographic area and huge social consequences, were selected and analyzed to put forward supervision strategies. RESULTS ＆ CONCLUSIONS： Both the case number of counterfeit drug and the people involved were increasing rapidly in Chi- na, increasing from 500 cases and 900 persons in 2011 to 2 500 cases and 6 000 persons in 2015. Among 50 typical cases, involved counterfeit drugs mostly focused on sexual dysfunction drugs （23.8%）, cosmetic drugs and weight loss drugs （19.6%）, antitussive and antiasthmatic drugs （14.2%）, anti-rheumatism drugs （13.9%）, antidiabetic drugs （7.3%） and antitumor drugs （6.6%）, etc. There were 42 cases of online counterfeit drugs sales （84%）, 46 cases of counterfeit drugs production and sales activities without a license （92%） and 3 cases of illegal counterfeit drugs purchase service （6%）. On the whole, manufacturing and selling counterfeit drugs activity in China has the following features, such as large sum of money is involved; criminal activities are very covert; most victims are low-income workers. It is suggested to strengthen the supervision work and innovative approach; en- hance the joint law enforcement of drug administration and public security organs, and promote connection between administrative law enforcement and criminal justice of drug cases; innovate information operation system and mechanism, and establish information sharing platform and reporting system; strengthen the monitoring of internet and cooperation with pharmaceutical companies; improve the publicity and deter criminals.
出处
《中国药房》
CAS
北大核心
2016年第28期3896-3899,共4页
China Pharmacy
基金
浙江省大学生科技创新活动计划暨新苗人才计划项目(No.2015R432012)
关键词
假药
现状
监管对策
研究
Counterfeit drugs
Status quo
Supervision strategy
Research
